INVO BioScience Inc. (INVO) Financial Statements (2025 and earlier)

Company Profile

Business Address 5582 BROADCAST COURT
SARASOTA, FL 34240
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9434752321,0561122,188
Cash and cash equivalents9434752321,0561122,188
Receivables25717714111775100
Inventory, net of allowances, customer advances and progress billings250266265254280271
Inventory250266265254280271
Other undisclosed current assets946806622365375251
Total current assets:2,3961,7251,2601,7928422,810
Noncurrent Assets
Operating lease, right-of-use asset2,3373,3693,3595,8584,0051,750
Property, plant and equipment441412826772659418
Long-term investments and receivables8448719161,0791,1321,174
Long-term investments8448719161,0791,1321,174
Intangible assets, net (including goodwill)9,5649,7689,9729,975  
Goodwill5,8795,8795,8798,225  
Intangible assets, net (excluding goodwill)3,6853,8894,0931,750  
Other undisclosed noncurrent assets2,1722,1722,172   
Total noncurrent assets:15,35916,59317,24617,6845,7973,341
TOTAL ASSETS:17,75518,31818,50619,4766,6396,151
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,3782,7982,3301,8521,8451,847
Accrued liabilities1,0221,2357225911,2021,221
Other undisclosed accounts payable and accrued liabilities1,3561,5631,6081,261642627
Deferred revenue41751340923016147
Business combination, contingent consideration, liability2,5002,5002,500   
Other liabilities350350350123  
Other undisclosed current liabilities2,3072,7952,4142,6792,4632,556
Total current liabilities:7,9528,9568,0034,8844,4694,450
Noncurrent Liabilities
Long-term debt and lease obligation1,1731,2141,2541,095  
Long-term debt, excluding current maturities1,1731,2141,2541,095  
Liabilities, other than long-term debt7,2668,1388,35613,1243,8751,613
Deferred income tax liabilities    222
Operating lease, liability2,2663,1383,3565,6223,8731,611
Business combination, contingent consideration, liability5,0005,0005,0007,500  
Total noncurrent liabilities:8,4399,3529,61014,2193,8751,613
Total liabilities:16,39118,30817,61319,1038,3446,063
Equity
Equity, attributable to parent, including:1,36410893373(1,705)88
Common stock000001
Additional paid in capital55,76752,92552,71156,19652,86952,421
Accumulated deficit(61,910)(59,415)(57,818)(55,823)(54,575)(52,334)
Other undisclosed equity, attributable to parent7,5066,5006,000   
Total equity:1,36410893373(1,705)88
TOTAL LIABILITIES AND EQUITY:17,75518,31818,50619,4766,6396,151

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues1,8371,5761,382975316348
Cost of revenue(862)(850)   (73)
Cost of goods and services sold      (61)
Gross profit:9757261,382975316275
Operating expenses(2,878)(1,672)(2,890)(1,861)(2,382)(2,582)
Operating loss:(1,903)(946)(1,508)(886)(2,066)(2,306)
Nonoperating expense(342)(648)(463)(360)(172)(244)
Interest and debt expense(40)(163)581(352)(175)(217)
Loss from continuing operations before equity method investments, income taxes:(2,286)(1,758)(1,391)(1,599)(2,413)(2,767)
Other undisclosed income (loss) from continuing operations before income taxes40163(581)352175 
Loss from continuing operations before income taxes:(2,245)(1,595)(1,972)(1,247)(2,238)(2,767)
Income tax expense (2)(23)(2)(3) 
Loss from continuing operations:(2,245)(1,597)(1,995)(1,248)(2,241)(2,767)
Other undisclosed net income      217
Net loss available to common stockholders, diluted:(2,245)(1,597)(1,995)(1,248)(2,241)(2,551)

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net loss:(2,245)(1,597)(1,995)(1,248)(2,241)(2,551)
Comprehensive loss, net of tax, attributable to parent:(2,245)(1,597)(1,995)(1,248)(2,241)(2,551)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: